Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EGB Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 5
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Genetics
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EGB Capital:
Typical Co-investors
EGB Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EGB Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amadeo New York, New York, United States
Banca Sella Group Biella, Italy, Piemonte
Castrol innoVentures Pangbourne, United Kingdom, West Berkshire
CEA Investissement France, Ile-de-France, Paris
ESRG Investments -
Hainei Ziben China, Guangdong Province, Huizhou
IMI Fondi Chiusi SGR Bologna, Emilia-Romagna, Italy
Lanying Information Technology China, Guangdong, Shenzhen
Mercia Asset Management England, Stratford-on-Avon, United Kingdom
NTT Plala Japan, Toshima
OperatorVC Ghaziabad, India, Uttar Pradesh
Oscor Florida, Palm Harbor, United States
Relia Japan, Kanagawa Prefecture, Kawasaki
SIG Chiyoda, Japan
START POINT Japan, Shinjuku
UCLB England, London, United Kingdom
Vitalbridge Capital China, Shanghai
Zhuoli lengqi China, Foshan, Guangdong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MiLaboratories

Biotechnology
Genetics
Software
10 Oct 2024 Sunnyvale, California, United States

SyntaxBio

Biotechnology
Medical
Product Research
17 Sep 2024 Chicago, Illinois, United States

Izote Biosciences

Biotechnology
Genetics
Life Science
$2M01 Feb 2024 Berkeley, California, United States

CellFE

Biotechnology
Health Care
$22M27 Sep 2023 California, United States

C. Light Technologies

Health Care
Medical
Medical Device
$4M02 Feb 2021 Berkeley, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EGB Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 5M
Peak activity year 2024
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

MiLaboratories

Biotechnology
Genetics
Software
10 Oct 2024 Sunnyvale, California, United States

SyntaxBio

Biotechnology
Medical
Product Research
17 Sep 2024 Chicago, Illinois, United States

Izote Biosciences

Biotechnology
Genetics
Life Science
$2M01 Feb 2024 Berkeley, California, United States

CellFE

Biotechnology
Health Care
$22M27 Sep 2023 California, United States

C. Light Technologies

Health Care
Medical
Medical Device
$4M02 Feb 2021 Berkeley, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: